Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats

Objectives. Statin-induced myopathy is one of the major causes of poor adherence and discontinuation of this medication. There are contrary results regarding association of vitamin D insufficiency with statin-induced myopathy. This study was done to determine the effect of the vitamin D3 analogue al...

Full description

Saved in:
Bibliographic Details
Main Authors: Bharti Chogtu, Balaji Ommurugan, Sereen R. Thomson, Sneha G. Kalthur
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2020/4704825
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850210195446169600
author Bharti Chogtu
Balaji Ommurugan
Sereen R. Thomson
Sneha G. Kalthur
author_facet Bharti Chogtu
Balaji Ommurugan
Sereen R. Thomson
Sneha G. Kalthur
author_sort Bharti Chogtu
collection DOAJ
description Objectives. Statin-induced myopathy is one of the major causes of poor adherence and discontinuation of this medication. There are contrary results regarding association of vitamin D insufficiency with statin-induced myopathy. This study was done to determine the effect of the vitamin D3 analogue alfacalcidol on Rosuvastatin-induced myopathy in rats. Methodology. Animals were divided into six groups with 6 rats in each group. Groups I and II acted as controls, Group III and Group IV were administered Rosuvastatin 120 mg/kg/day and 160 mg/kg/day, Groups V and VI were administered alfacalcidol 0.1 μg/kg/day in addition to Rosuvastatin 120 mg/kg/day and 160 mg/kg/day, respectively. All drugs were administered orally for 15 days. Plasma creatine kinase (CK) levels were estimated on day 10 and day 15. Animals were sacrificed and muscles were sent for histopathological examination. Results. On day 10, Groups V and VI showed a statistically significant increase in plasma CK levels as compared to the control (p<0.001) and were significantly lower (p<0.001) as compared to Groups III and IV, respectively. However, on day 15, plasma CK levels in Groups V and VI were comparable to those of control groups with a nonsignificant difference (p>0.05). On comparing the histology, Groups V and VI showed a significant difference as compared to statin-only groups (Groups III and IV) as there were signs of regeneration, less splitting, and fragmentation of muscle fibres. Conclusion. The present study shows that the vitamin D analogue alfacalcidol prevents statin-induced myopathy. The serum CK levels are comparable to the control group on day 15 of vitamin D administration.
format Article
id doaj-art-94c54e67f7354aa5b89f9c3ac7eee45c
institution OA Journals
issn 2356-6140
1537-744X
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-94c54e67f7354aa5b89f9c3ac7eee45c2025-08-20T02:09:48ZengWileyThe Scientific World Journal2356-61401537-744X2020-01-01202010.1155/2020/47048254704825Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar RatsBharti Chogtu0Balaji Ommurugan1Sereen R. Thomson2Sneha G. Kalthur3Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka 576104, IndiaBioPharma Solutions, Chennai, Tamil Nadu, IndiaAPCER Life Sciences, Ahmedabad, Gujarat, IndiaDepartment of Anatomy, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka 576104, IndiaObjectives. Statin-induced myopathy is one of the major causes of poor adherence and discontinuation of this medication. There are contrary results regarding association of vitamin D insufficiency with statin-induced myopathy. This study was done to determine the effect of the vitamin D3 analogue alfacalcidol on Rosuvastatin-induced myopathy in rats. Methodology. Animals were divided into six groups with 6 rats in each group. Groups I and II acted as controls, Group III and Group IV were administered Rosuvastatin 120 mg/kg/day and 160 mg/kg/day, Groups V and VI were administered alfacalcidol 0.1 μg/kg/day in addition to Rosuvastatin 120 mg/kg/day and 160 mg/kg/day, respectively. All drugs were administered orally for 15 days. Plasma creatine kinase (CK) levels were estimated on day 10 and day 15. Animals were sacrificed and muscles were sent for histopathological examination. Results. On day 10, Groups V and VI showed a statistically significant increase in plasma CK levels as compared to the control (p<0.001) and were significantly lower (p<0.001) as compared to Groups III and IV, respectively. However, on day 15, plasma CK levels in Groups V and VI were comparable to those of control groups with a nonsignificant difference (p>0.05). On comparing the histology, Groups V and VI showed a significant difference as compared to statin-only groups (Groups III and IV) as there were signs of regeneration, less splitting, and fragmentation of muscle fibres. Conclusion. The present study shows that the vitamin D analogue alfacalcidol prevents statin-induced myopathy. The serum CK levels are comparable to the control group on day 15 of vitamin D administration.http://dx.doi.org/10.1155/2020/4704825
spellingShingle Bharti Chogtu
Balaji Ommurugan
Sereen R. Thomson
Sneha G. Kalthur
Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats
The Scientific World Journal
title Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats
title_full Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats
title_fullStr Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats
title_full_unstemmed Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats
title_short Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats
title_sort effect of vitamin d analogue on rosuvastatin induced myopathy in wistar rats
url http://dx.doi.org/10.1155/2020/4704825
work_keys_str_mv AT bhartichogtu effectofvitamindanalogueonrosuvastatininducedmyopathyinwistarrats
AT balajiommurugan effectofvitamindanalogueonrosuvastatininducedmyopathyinwistarrats
AT sereenrthomson effectofvitamindanalogueonrosuvastatininducedmyopathyinwistarrats
AT snehagkalthur effectofvitamindanalogueonrosuvastatininducedmyopathyinwistarrats